Clinical OMICS

MAR-APR 2019

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link: https://clinicalomics.epubxp.com/i/1093879

Contents of this Issue

Navigation

Page 2 of 51

VOL. 6, Issue No. 2 March/April 2019 www.clinicalomics.com March/April 2019 Clinical OMICs 1 @ClinicalOMICs 41 | We Have the Tools to Advance Precision Medicine, Why Aren't We Using Them? Cofactor Genomics COO David Messina makes the case that single-analyte testing doesn't cut it in today's world of precision medicine. 44 | What Does It Take to Drive Genomics into the Clinic? Francis daSouza, CEO of Illumina, says actionability of data, access for patients, and a broad educational effort are required to increase uptake of genomic medicine. 46 | Glioblastoma Sex Differences Uncovered: Cancer Outcomes May Be Improved by Tailoring Treatments Based on Sex Differences 40 | NEW PRODUCTS 48 | INDUSTRY EVENTS Luminaries From George Church and Elaine Mardis to Liz Worthey and Stephen Kingsmore, our roster of experts share how their work has impacted the world of "omics" and precision medicine—and take a peek into the future. 20 A digital publication of GEN, a Mary Ann Liebert, Inc. company APRIL 23, 2014 Translating OMICs into Cancer Biology and Medicine Payers Wrestle with Reimbursement Best New Clinical Apps Innovator: Lawrence Brody New Products & More Translating OMICs into Cancer Biology and Medicine Payers Wrestle with Reimbursement Best New Clinical Apps Innovator: Lawrence Brody New Products & More Innovative Practices, Actionable Results MAY 29, 2014 ISSUE No. 4 A digital publication of GEN, a Mary Ann Liebert, Inc. company Cancer Diagnostics Leverage Decreasing Cost of Sequencing Labs Face Medicare Cuts, New Codes Exosomes Patenting Medical Diagnostics New Products & More Cancer Diagnostics Leverage Decreasing Cost of Sequencing Labs Face Medicare Cuts, New Codes Exosomes Patenting Medical Diagnostics New Products & More Innovative Practices, Actionable Results Honing Prenatal Screening Tests Near or Far? Omics Data Management, Analysis, and Action Smartphone Based Biosensors —Just What the mDiagnostician Ordered Events Roundup, New Products & More Honing Prenatal Screening Tests Near or Far? Omics Data Management, Analysis, and Action Smartphone Based Biosensors —Just What the mDiagnostician Ordered Meeting Roundup, New Products & More ISSUE No. 9 A digital publication of GEN, a Mary Ann Liebert, Inc. company Innovative Practices, Actionable Results NOVEMBER/DECEMBER 2017 VOL. 4, ISSUE No. 6 Stephen Kingsmore Speeds Forward POC Testing Revs Up Unlocking the Microbiome GTEx Links Variants to Expression Stephen Kingsmore Speeds Forward POC Testing Revs Up Unlocking the Microbiome GTEx Links Variants to Expression VOL. 4, ISSUE No. 5 DECEMBER 10, 2014 ISSUE No. 15 A digital publication of GEN, a Mary Ann Liebert, Inc. company Molecular Diagnostics in Personalized Medicine Noninvasive Molecular Diagnostics for Cancer Genomic Medicine: Balancing Cost and Value The National Access Project for Cancer Testing Meeting Roundup New Products & More Noninvasive Molecular Diagnostics for Cancer Genomic Medicine: Balancing Cost and Value The National Access Project for Cancer Testing Meeting Roundup New Products & More Noninvasive Molecular Diagnostics for Cancer Genomic Medicine: Balancing Cost and Value The National Access Project for Cancer Testing Meeting Roundup New Products & More A digital publication of GEN, a Mary Ann Liebert, Inc. company JULY/AUGUST 2017 VOL. 4, ISSUE No. 4 Clinical Genomics Leader Heidi Rehm Talks Shop NIPT Eyes Single-Cell Techniques NGS Diagnostics Come of Age Geisinger's MyCode Powers Precision Medicine Clinical Genomics Leader Heidi Rehm Talks Shop NIPT Eyes Single-Cell Techniques NGS Diagnostics Come of Age Geisinger's MyCode Powers Precision Medicine Molecular Diagnostics in Personalized Medicine JANUARY/FEBRUARY 2019 A Larger Role for Genomics in Immuno-Oncology Liquid Biopsy Gets Ready for Prime Time Molecular Diagnostics in Personalized Medicine MARCH/APRIL 2017 VOL. 4, ISSUE No. 2 A Larger Role for Genomics in Immuno-Oncology Liquid Biopsy Gets Ready for Prime Time Nanopore Sequencing: The New Front Line of Infectious Disease Diagnostics Point-of-Care Molecular Diagnostics Evolve CASE STUDY: Taking Control of Operational Genomics New Products & More VOL. 2, ISSUE No. 7 Molecular Diagnostics in Personalized Medicine Nanopore Sequencing: The New Front Line of Infectious Disease Diagnostics Point-of-Care Molecular Diagnostics Evolve CASE STUDY: Taking Control of Operational Genomics New Products & More FEBRUARY 2015 VOL. 2, ISSUE No. 2 Molecular Diagnostics in Personalized Medicine Beyond the Sequence Uncle Sam Casts Wary Eye on Clinical Lab Billing Case Study: Discovery of Functional Serum Biomarkers Meeting Roundup New Products & More Beyond the Sequence Uncle Sam Casts Wary Eye on Clinical Lab Billing Case Study: Discovery of Functional Serum Biomarkers Meeting Roundup New Products & More Beyond the Sequence Uncle Sam Casts Wary Eye on Clinical Lab Billing Case Study: Discovery of Functional Serum Biomarkers Meeting Roundup New Products & More Researchers Turn to the Cloud as Genomic Data Explodes Advanced Genomic Methods Battle Against Microbial Resistance Coalition Seeks Broader Adoption of NIPT Health Systems Combine EHR and Genomics Data Molecular Diagnostics in Personalized Medicine JANUARY/FEBRUARY 2017 VOL. 4, ISSUE No. 1 Researchers Turn to the Cloud as Genomic Data Explodes Advanced Genomic Methods Battle Against Microbial Resistance Coalition Seeks Broader Adoption of NIPT Health Systems Combine EHR and Genomics Data Commonplace Sequencing Makes Disease Less Rare Industry Awaits Word from FDA on LDTs MD Anderson, Scripps Health Partner for Cancer Care ASCO's CancerLinQ Picks Up Steam Molecular Diagnostics in Personalized Medicine NOVEMBER/DECEMBER 2016 VOL. 3, ISSUE No. 10 Commonplace Sequencing Makes Disease Less Rare Industry Awaits Word from FDA on LDTs MD Anderson, Scripps Health Partner for Cancer Care ASCO's CancerLinQ Picks Up Steam MAY 15, 2014 ISSUE No. 3 A digital publication of GEN, a Mary Ann Liebert, Inc. company Future Cancer Care Anticipating "Panomics" with Bioinformatics Bringing Informed Interpretation to Vexing Variants Best Clinical Apps Innovator: Leroy Hood New Products & More Future Cancer Care Anticipating "Panomics" with Bioinformatics Bringing Informed Interpretation to Vexing Variants Best Clinical Apps Innovator: Leroy Hood New Products & More Innovative Practices, Actionable Results VOL. 5, ISSUE NO. 6 SEPTEMBER/OCTOBER 2018 100,000 Genomes Club New Biomarkers from Wearables More CRISPR Questions Keeping the Beat in Atrial Fibrillation ANNIVERSARY ISSUE th Five-Year Super Successes In the time since the first issue of Clinical OMICs, these six companies have grown significantly and helped define their niches in genomics and precision medicine. 36 3 | FROM THE EDITOR A Quick Pause to Celebrate Five Successful Years 6 | Amplification Litigation: Human Genome Project Leader Among Shareholders in Legal Wrangle over Milestones for PCR Alternative 10 | FEATURE Wearable Data Revolution: Digital Biomarkers Are Transforming Research, Promising a Revolution in Healthcare 14 | FEATURE Big Data and Clinical Genomics: Progress Is Being Made Toward Using Big Data for Genomics-Guided Precision Medicine Above (top right) Clinical OMICs; (top left) Ca-ssis / Getty Images; (middle left) Fitbit; (middle right) Ca-ssis / Getty Images ANNIVERSARY ISSUE

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - MAR-APR 2019